Wednesday, 28 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Price Movement Clarification

Beta Drugs Price Movement Clarification

Beta Drugs Limited clarified to NSE that recent significant share price movements are purely market-driven. The company confirmed there is no undisclosed price-sensitive information or material announcements pending. Beta Drugs maintains compliance with SEBI transparency regulations and continues to monitor market activity.

Source

NSE filing, NSE: BETA. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Beta Drugs Ltd: key numbers

Share price
₹1,976.80
Market cap
₹2,191 Cr
Revenue (annual)
₹384.8 Cr
Net profit (annual)
₹41.48 Cr
P/E (TTM)
42.2×Sector 46.1×
Promoter holding
58.91%-0.19% QoQ
FII holding
1.37%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Beta Drugs Ltd

All →

Other price movement clarification announcements

All →